News
Latest
Article
European Pharmaceutical Review Issue 1 2026
EPR Issue 1 includes articles on manufacturing, drug delivery, environmental monitoring, analytical techniques and more.
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
Special reports
NewsJohnson & Johnson’s Caplyta demonstrates phase III promise for depression
Combination therapy comprising of an antidepressant and small molecule drug significantly boosted remission rates in adults with major depressive disorder.
NewsChemical assessment in Europe to be streamlined under new legislation
The European Commission’s new framework aims to improve safety assessment of chemicals to better protect human health and the environment.
NewsEndotoxin testing milestone reached with European Pharmacopoeia’s animal shift
The quality control (QC) standards publication sets animal-free bacterial endotoxins testing (BET) as the new norm in Europe.
NewsImpurities findings could enhance peptide drug safety
EpiVax and Cubrc research supports FDA guidance on impurity risk assessment in generic peptides.
Opinion
- Previous
- Next
All news articles
News
Food-grade materials potential alternative for one-dose pharmaceutical packaging
Food packaging films could enhance stability of hygroscopic medications, supporting improved therapeutic outcomes, study finds.
News
New FDA draft guidance to enhance safety of genome editing therapies
Recommendations support next-generation sequencing-based safety evaluation of off-target editing for personalised gene therapies.
News
Regeneron and Telix collaborate to advance biologics-based radiopharmaceuticals
Potential $4.3 billion partnership deal to develop next-generation radiopharmaceutical therapies for hard-to-treat cancers.
News
European Commission expands Dupixent approval in chronic spontaneous urticaria
New EU authorisation gives monoclonal antibody potential as new standard of care for the chronic skin condition.
News
Analytical framework demonstrates potential in single-use chromatographic purification
Digitally-driven technique supports development of autonomous, continuous biomanufacturing technologies.
News
CAR-T therapy could treat severe autoimmune diseases, shows study
Earlier intervention in severe autoimmune diseases may help prevent complications following previous ineffective treatments.
News
Gilead strengthens ADC capabilities with $5bn Tubulis acquisition
Deal expands the companies’ existing two-year partnership and builds Gilead’s oncology pipeline.
News
Surface bioburden study offers insight on non-sterile manufacturing
Microbial load fell within the predefined limit, suggesting contamination was controlled during a single time point.
News
Trump imposes 100 percent tariff on imported pharmaceuticals
US administration proffers leeway on tariffs for some drugs, with UK exports benefitting from exemption under the recent UK-US partnership.
News
FDA approves Lilly’s small molecule obesity pill Foundayo
New GLP-1 therapy Foundayo is Eli Lilly’s second obesity medicine to be authorised for use in the US.
News
Editas Medicine’s gene-edited therapy reni-cel sees early clinical success
The CRISPR–Cas12a autologous stem cell therapy improved total haemoglobin levels in participants with sickle cell disease.
News
Lilly advances neuroscience portfolio with $7.8bn acquisition of Centessa
Acquisition includes a potential best-in-class asset for excessive daytime sleepiness, broadening Lilly’s capabilities into sleep medicine.
News
UCB’s TK2d therapy Kygevvi approved by European Commission
Authorisation of the small molecule therapy in the EU represents a new option for thymidine kinase 2 deficiency, builds on earlier US FDA approval.
News
Framework supports microbiota assessment in cleanroom changing rooms
Case study presents a potential benchmarking model for microbial trend data and a data presentation format for pharmaceutical cleanrooms.
News
Holistic automation for data integrity, usability and sustainability
IMA Active explores how interconnected, human-centric systems that implement advanced automation and usability can enhance operational efficiency and sustainability in tablet manufacturing.
News
Novo Nordisk’s Awiqli first FDA-approved once-weekly basal insulin
The type 2 diabetes injection reduces administration frequency from daily to once per week, enhancing convenience for patients.
News
Merck expands haematology pipeline with $6.7bn acquisition of Terns Pharmaceuticals
Deal strengthens Merck’s oncology portfolio with addition of a potential best-in-class oral TKI for chronic myeloid leukaemia.
News
UCB positions new Georgia biologics facility as future US manufacturing hub
The biopharmaceutical company’s latest manufacturing venture represents one of the largest investments in Georgia’s history.
News
AstraZeneca’s Imfinzi wins EU-first immunotherapy approval in early GI cancers
The approval represents the pharmaceutical company’s third perioperative approval in Europe for an Imfinzi-based regimen.
News
Gilead acquires potential first-in-class T cell engager in $2bn deal with Ouro Medicines
T cell engager gamgertamig could redefine standard of care for immune-mediated diseases.